Tuesday, 02 January 2024 12:17 GMT

Erasca To Present At Upcoming Conferences In November


Date:

(MENAFN- GlobeNewsWire - Nasdaq) SAN DIEGO, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that management will participate in the following investor conferences in November 2026 and will also participate in one-on-one investor meetings at each of these conferences.

Guggenheim 3 rd Annual Healthcare Innovation Conference
Location: InterContinental Boston, Boston, MA
Format: Fireside Chat
Date and Time: Tuesday, November 10, 3:30 pm Eastern Time

Stifel 2026 Healthcare Conference
Location: Lotte New York Palace, New York, NY
Format: Fireside Chat
Date and Time: Wednesday, November 11, 9:20 am Eastern Time

Jefferies Global Healthcare Conference
Location: The Waldorf Hilton, London, UK
Format: Fireside Chat
Date and Time: Wednesday, November 18, 12:30 pm Greenwich Mean Time

A live audio webcast of the events will be available online at Erasca.com/events. An archived replay of the events will be available for 30 days following the webcast at Erasca.com/events.

About Erasca
At Erasca, our name is our mission: To erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Our company was co-founded by leading pioneers in precision oncology and RAS targeting to create novel therapies and combination regimens designed to comprehensively shut down the RAS/MAPK pathway for the treatment of patients with cancer. We believe our team's capabilities and experience, further guided by our scientific advisory board which includes the world's leading experts in the RAS/MAPK pathway, uniquely position us to achieve our bold mission of erasing cancer.

Contact:
Joyce Allaire
LifeSci Advisors, LLC
...

Media Contact:
Michael Fitzhugh
LifeSci Communications
...


MENAFN03112026004107003653ID1111908719


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search